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Two sublines of mouse L929 cells designated L929B and L929M were studied. The L929B cells, which dis- 
played a 2-3-fold higher IFN production in response to Sendai virus than that of the L929M cells, had 
a higher sensitivity to the antiviral and priming effects of IFN and were more resistant to VSV. In good 
accord with the amount of IFN produced, more translatable IFN mRNA was isolated from the L929B cells. 
IFN production and IFN mRNA activities were proportionally increased in the IFN-primed cultures of 
both sublines. Results indicate that both inherent and priming-induced increased-IFN production are based 
on pretranslational control mechanisms. 
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1. INTRODUCTION 
A wide variation of control mechanisms exists 
for the regulation of expressions of inducible 
proteins in eukaryotic cells. IFNs are proteins with 
antiviral, cell growth-inhibitory and immuno- 
modulatory activities, synthesized by cells upon 
virus infection or treatment with double-stranded 
nucleic acids. The effectivity of IFN induction is 
dependent on the type of the producing cell and on 
the nature of the inducer. It has also been reported 
that the treatment of cells with homologous IFN 
before induction primes subsequent IFN produc- 
tion [l]. The point of attack of priming in the pro- 
cess of IFN synthesis has been extensively studied, 
but there is some disagreement as to the exact 
nature of the process involved [2-51. Since we have 
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isolated two L929 sublines that had different IFN- 
producing capacities and in which there were dif- 
ferent degrees of enhancement of IFN production 
by priming, we considered them as advantageous 
tools which might provide comprehensive data on 
the mechanisms determining the effectivities of 
IFN production and of priming. The main objec- 
tive of the present work was therefore to determine 
whether the enhanced IFN production under these 
conditions was also manifested in the amount of 
IFN mRNA or not. In order to answer this ques- 
tion, we compared the titres of IFN produced and 
the amounts of translatable IFN mRNA in these 
two sublines of L929 cells. 
2. MATERIALS AND METHODS 
2.1. Cells 
The sublines L929B and L929M were isolated 
after serial mutagenesis from a mouse L929 cell 
line originally provided by G.L. Toms (Depart- 
ment of Microbiology, University of Birmingham, 
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Birmingham, England). Both sublines were serially 
passaged in MEM supplemented with 5% FCS and 
antibiotics. Their characteristics were not reversed 
during more than 50 passages of the cells. 
2.2. IFN titration 
This was carried out as described [6]. IFN titres 
are given in reference units. 
2.3. Extraction and assay of IFN mRNA 
The poly(A)-containing RNA fraction was 
isolated from the IFN-producing cells with the 
method of Ullrich et al. [7]. The translational ac- 
tivity of IFN mRNA present in these preparations 
was quantitated by injection into Xenopus laevis 
oocytes [8]. The titre of translated IFN was deter- 
mined on mouse L929 cells. 
Table 1 
Characteristics of L929B and L929M sublines and the 
IFNs they produce 
Characteristics Cells 
L929B L929M 
Population doubling time (h) 21 21 
Spontaneous IFN formation none none 
50% virus inhibitory concentration 
of IFN (W/ml) 0.15 0.8 
Minimal priming dose of IFN 
(IU/ml) 0.1 1.0 
TCIDso of VW (PFU/ml)a 6.8 x lo4 7.0 x 10’ 
Neutralization titre of MuIFN 
antiserum against the IFN 
producedb 2.4 x lo4 2.4 x lo4 
Residual activity of IFN after 
30 min at 56°C (olo) 1.5-2 1.5-2 
Molecular masses of peak IFN 22-24 22-24 
activities (kDa)’ 28-32 28-32 
a The VSV preparation used for determination of the 
susceptibilities of L929 cells to this virus had a titre of 
1O’.9 PFU/ml on primary chick embryo fibroblasts 
b Dilution of MuIFN antiserum (G-024-501-568; 
provided by the Antiviral Substances Program, 
National Institute of Health, Bethesda, MD, USA) 
required for neutralization of 10 IU of IFN produced 
by L929B or L929M cells 
’ Gel filtration analysis of IFNs was performed on a 
Sephadex G-75 column (2.5 x 70 cm) 
12315 
Fig.1. Effects of IFN pretreatment on IFN production 
and IFN mRNA content of L929B and L929M cells. 
Confluent cultures grown in 150 cm2 plastic tissue 
culture flasks were pretreated for 10 h with 30 W/ml of 
a partially purified preparation of mouse L cell IFN with 
a specific activity of 106.5 IU/mg protein. For IFN 
induction 3 ml of 1.8 x lo3 HAU/ml concentrated and 
purified Sendai virus (parainfluenza 1) was added to 
each flask, after which 1 x 10’ cells were collected at 
different times for the determination of IFN mRNA 
content. The IFN production was determined on the 
corresponding culture media. (0) Control IFN; (0) 
primed IFN; (A) control IFN mRNA; (A) primed IFN 
mRNA. The points represent mean values of four 
independent experiments. 
3. RESULTS 
The L929B subline was about 5-lo-times more 
susceptible to the antiviral and priming effects of 
IFN, and approx. lOOO-times more VSV was re- 
quired to infect these cells than L929M cells. 
However, we found no difference between the im- 
munological and physico-chemical characteristics 
of the IFNs produced by them (table 1). 
Unprimed (control) L929B cells produced 
2-3-times more IFN than did L929M cells. For the 
primed cultures the corresponding ratio was ap- 
prox. 2-times higher and the kinetics of IFN pro- 
duction was accelerated. The amount of 
translatable IFN mRNA was proportional to the 
amount of IFN produced. The L929B cells, which 
produced more IFN in response to induction with 
Sendai virus, likewise contained more IFN mRNA 
than did the L929M cells. The enhancement of IFN 
production and the amount of IFN mRNA were 
also proportional in response to priming (fig.l). 
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4. DISCUSSION REFERENCES 
The higher IFN mRNA levels in L929B cells in- 
dicate that the inherent differences in IFN- 
producing capacities are manifested pretransla- 
tionally. 
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